|
|
| (11 intermediate revisions not shown) |
| Line 4: |
Line 4: |
| | | | |
| | ==Intellectual Property== | | ==Intellectual Property== |
| - | *Ask UBC [http://www.uilo.ubc.ca tech transfer office]
| + | [https://2012.igem.org/Team:British_Columbia/Human_Practices/FAQ FAQ] |
| - | **Mike Gold suggested dropping his name to Ian Bell, Technology Transfer Manager for the Life Sciences | + | *IP [https://docs.google.com/spreadsheet/ccc?key=0AngNayWeH_rTdHdMb09iNDNaYV95TllLazFNTmdCQlE Survey] |
| - | **Dr. Andre Marziali, EngPhys Director
| + | *IP Survey [https://docs.google.com/spreadsheet/ccc?key=0AngNayWeH_rTdC1QTTVoXzdHc0pZY0RxTFBOcy1Bb1E Results] |
| - | *OSLI guidance? | + | |
| | *[http://biobricks.org/bpa/faq/ biobrick agreement] | | *[http://biobricks.org/bpa/faq/ biobrick agreement] |
| - | *[https://2011.igem.org/Team:UQ-Australia/Human_Practices]
| |
| | ===Previous iGEM work=== | | ===Previous iGEM work=== |
| - | ===Survey questions for iGEM===
| + | [https://2011.igem.org/Team:UQ-Australia/Human_Practices 2011 UQ-australia] |
| - | Blurb about IP & patents.
| + | [http://classic.the-scientist.com/blog/display/53835/ 2010 The Scientist Article] |
| - | * What experiences have you had with IP in iGEM?
| + | [https://2010.igem.org/Team:Caltech/Human_Impact 2010 Caltech] |
| - | ** How did you approach the process?
| + | [http://igem.uwaterloo.ca/share/Outreach/Human%20Practices%202010/Role%20of%20Biotech%20IPR%20in%202030.pdf 2010 Waterloo] |
| - | ** What resources did you use? Do you know how to find resources?
| + | [https://2007.igem.org/wiki/index.php/Edinburgh/Intellectual_Property_Talk 2007 Edinburgh] |
| - | ** What issues did you encounter?
| + | [https://2008.igem.org/Team:UCSF/Human_Practices 2008 UCSF] |
| - | ** Have you consulted anyone outside of your team about IP?
| + | |
| - | ** What would you like to have done to improve your experience?
| + | |
| - | ** Do you have experience outside of iGEM?
| + | |
| - | * Has IP concerns affected your project? If so, how?
| + | |
| - | * What do you want to know about IP that we can help you with?
| + | |
| - | * Are you worried about the IP aspect of your project?
| + | |
| - | * Would you be interested in a FAQ about IP for iGEM?
| + | |
| - | ** What type of format would you prefer? (e.g., video, FAQ page, "Choose your own adventure" walkthrough, etc.)
| + | |
| - | * Are you interested in protecting our own IP (e.g., through patenting)?
| + | |
| - | * Do you think Biobricks can be patented?
| + | |
| - | * Do you think iGEM teams can produce patentable projects?
| + | |
| - | * Do you think you can take your patent country to country easily?
| + | |
| - | * How much do you think patenting something costs?
| + | |
| - | * How much time do you think the patenting process would take?
| + | |
| - | * What is your main IP concern: Use of existing patents or establishing ownership of new patents?
| + | |
| - | * Do you know if your team's project depends on anything that is protected by IP rights?
| + | |
| - | ** Do you think this would get in the way for patenting your own project?
| + | |
| - | * What aspect of dealing with IP would you like the most help with? What would you like to get out of a FAQ?
| + | |
| - | * How do you think IP protection affects innovation?
| + | |
| - | ** Do you think IP protection and open source ideals can coexist?
| + | |
| - | * How does IP help/hurt your project?
| + | |
| - | ===Questions for Professionals===
| + | |
| - | * What's a good rule of thumb for determining what things in biotechnology be patentable?
| + | |
| - | ** Does that strongly vary among jurisdiction?
| + | |
| - | * What are particularly difficult jurisdictions to get patents in?
| + | |
| - | * What pitfalls might an iGEM team run into?
| + | |
| - | * Do you think it's worthwhile for iGEM teams to explore patenting for their projects? (ask Randy Retberg/iGEM HQ too)
| + | |
| - | * How do you think IP protection affects innovation?
| + | |
| - | * Is it generally worth getting a patent in just one country?
| + | |
| - | * How does the industry approach/handle patents held by researchers?
| + | |
| - | * How does IP help/hurt your project?
| + | |
| - | * How do you decide if something is worth patenting/licensing?
| + | |
| - | * What are the university's policies concerning ownership of researchers' work? How are they generally compared to other universities?
| + | |
| - | * How does the UILO/TTO help researchers reach their goals in getting IP protection?
| + | |
| - | * What happens when someone infringes a patent?
| + | |
| - | * What happens when someone doesn't give the university ownership of the IP? For example, if the researcher claims that he/she worked on it on their own time or at another institution?
| + | |
| - | * How does company sponsorship affect IP ownership?
| + | |
| - | * What are some typical problems researchers encounter?
| + | |
| | | | |
| | ==Community Outreach== | | ==Community Outreach== |
| | | | |
| - | ==US/Canada Regulatory Concerns==
| |
| - | *illegitimate DNA transfer (strains on band-aids in magazines?)
| |
| | ==OSLI feedback== | | ==OSLI feedback== |
| | *Biosafety | | *Biosafety |
| | *Efficiency | | *Efficiency |
| | *Environmental | | *Environmental |
"
